Gilead Sciences, Inc. (TSX:GILD)
Canada · Delayed Price · Currency is CAD 28.97
-0.15 (-0.52%)
Oct 6, 2026, 3:42 PM EST
Gilead Sciences Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 254,310 | 208,796 | 165,636 | 133,307 | 145,732 | 115,262 | |
Market Cap Growth | 30.38% | 26.06% | 24.25% | -8.53% | 26.44% | 23.86% |
Enterprise Value | 284,571 | 228,488 | 189,331 | 154,146 | 169,659 | 140,545 |
Last Close Price | 28.97 | 24.84 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 17.89 | 239.83 | 17.82 | 23.45 | 14.63 |
PS Ratio | 5.88 | 5.17 | 4.00 | 3.72 | 3.95 | 3.34 |
PB Ratio | 15.25 | 6.73 | 5.98 | 4.44 | 5.08 | 4.32 |
P/FCF Ratio | 13.84 | 16.10 | 11.17 | 13.60 | 12.91 | 8.43 |
P/OCF Ratio | 13.21 | 15.20 | 10.63 | 12.61 | 11.87 | 8.00 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.57 | 5.66 | 4.58 | 4.31 | 4.60 | 4.07 |
EV/EBITDA Ratio | 13.55 | 11.43 | 9.78 | 9.71 | 9.59 | 7.94 |
EV/EBIT Ratio | 16.90 | 14.10 | 12.31 | 12.51 | 11.42 | 9.31 |
EV/FCF Ratio | 15.48 | 17.62 | 12.77 | 15.73 | 15.02 | 10.28 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.24 | 1.13 | 1.42 | 1.13 | 1.22 | 1.30 |
Debt / EBITDA Ratio | 1.78 | 1.73 | 2.01 | 2.11 | 1.95 | 1.93 |
Debt / FCF Ratio | 2.03 | 2.70 | 2.65 | 3.46 | 3.09 | 2.53 |
Net Debt / Equity Ratio | 1.82 | 0.57 | 0.82 | 0.71 | 0.84 | 0.88 |
Net Debt / EBITDA Ratio | 1.46 | 0.89 | 1.17 | 1.34 | 1.35 | 1.33 |
Net Debt / FCF Ratio | 1.65 | 1.37 | 1.53 | 2.18 | 2.12 | 1.72 |
Asset Turnover | 0.58 | 0.50 | 0.48 | 0.43 | 0.42 | 0.40 |
Inventory Turnover | 3.29 | 3.58 | 3.58 | 3.62 | 3.62 | 3.35 |
Quick Ratio | 0.90 | 1.23 | 1.33 | 1.15 | 1.03 | 1.02 |
Current Ratio | 1.26 | 1.55 | 1.60 | 1.43 | 1.29 | 1.27 |
Return on Equity (ROE) | -20.68% | 40.66% | 2.29% | 25.54% | 21.60% | 31.57% |
Return on Assets (ROA) | 14.09% | 12.52% | 11.03% | 9.31% | 10.46% | 10.94% |
Return on Invested Capital (ROIC) | 34.37% | 27.92% | 19.78% | 19.03% | 21.25% | 21.68% |
Return on Capital Employed (ROCE) | 30.90% | 25.00% | 22.70% | 18.30% | 21.10% | 21.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.81% | 5.59% | 0.42% | 5.61% | 4.26% | 6.83% |
FCF Yield | 7.23% | 6.21% | 8.95% | 7.35% | 7.75% | 11.86% |
Dividend Yield | 2.29% | 17.44% | - | - | - | - |
Payout Ratio | - | 47.04% | 816.25% | 67.24% | 80.77% | 57.91% |
Buyback Yield / Dilution | 1.39% | 0.24% | 0.24% | 0.32% | 0.08% | 0.08% |
Total Shareholder Return | 3.68% | 17.69% | 0.24% | 0.32% | 0.08% | 0.08% |